Shows & Panels
- Accelerate and Streamline for Better Customer Service
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Client Virtualization Solutions
- Data Protection in a Virtual World
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Feds in the Cloud
- Health IT: A Policy Change Agent
- Improving Healthcare Outcomes through IT Policy
- IT Innovation in the New Era of Government
- Making Dollars And Sense Out of Data Center Consolidation
- Navigating the Private Cloud
- One Step to the Cloud, Two Steps Toward Innovation
- Path to FDCCI Compliance
- Take Command of Your Mobility Initiative
Shows & Panels
6 European countries pull Novartis flu vaccines
Friday - 10/26/2012, 1:44pm EDT
BERLIN (AP) - Six European countries have ordered a temporary ban on the import or use of some Novartis flu vaccines.
Austria, France, Germany, Italy, Spain and Switzerland have limited the use of Fluad or Aggripal, or both, after the company reported the appearance of small particles in the vaccine to Italian authorities.
Italian health officials say the company knew of the problem since July but only notified them this month.
Novartis spokesman Eric Althoff declined to specify Friday how long the Basel, Switzerland-based pharmaceutical giant waited before telling authorities.
In an email, Althoff said that "once the deviation was seen, an investigation was started and the findings were shared with the Italian Ministry of Health."
Other flu vaccines are available in the affected countries but delivery bottlenecks are expected in some regions.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)